Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.731,42
-0,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hikma Pharmaceuticals Plc (HIK) Hikma Pharmaceuticals Plc (HIK) Notizie

HIK

Hikma Pharmaceuticals (HIK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HIK
DataOraFonteTitoloSimboloCompagnia
09/05/202410:49RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
25/04/202415:28RNS Regulatory NewsHikma Pharmaceuticals Plc Result of AGMLSE:HIKHikma Pharmaceuticals Plc
25/04/202411:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
25/04/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
15/04/202417:43RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma appoints new President of Generics businessLSE:HIKHikma Pharmaceuticals Plc
02/04/202410:50RNS Regulatory NewsHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
22/03/202410:21RNS Regulatory NewsHikma Pharmaceuticals Plc Annual Financial Report and Notice of AGMLSE:HIKHikma Pharmaceuticals Plc
01/03/202411:17RNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
22/02/202410:42Alliance NewsAlliance NewsTOP NEWS: Hikma boosts dividend after year of "significant progress"LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:09Alliance NewsAlliance News*Hikma Pharmaceuticals says core operating profit to be in range of USD660m to USD700mLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:08Alliance NewsAlliance News*Hikma Pharmaceuticals expect revenue to grow in the range of 4% to 6%LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:08Alliance NewsAlliance News*Hikma Pharmaceuticals confident that strategy will continue to deliver growth in 2024LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:07Alliance NewsAlliance News*Hikma Pharmaceuticals declares FY dividend of 73 US cents per share vs 56 cents YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:06Alliance NewsAlliance News*Hikma Pharmaceuticals 2023 pretax profit USD520m vs USD233m YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:06Alliance NewsAlliance News*REPEAT: Hikma Pharmaceuticals 2023 revenue USD2.88b vs USD2.52b YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:05Alliance NewsAlliance News*Hikma Pharmaceuticals 2023 USD2.88b vs USD2.52b YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Final ResultsLSE:HIKHikma Pharmaceuticals Plc
21/02/202419:20UK RegulatoryHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityLSE:HIKHikma Pharmaceuticals Plc
20/02/202418:24Alliance NewsAlliance NewsEARNINGS PREVIEW: Eyes on Hikma's outlook ahead of full-year resultsLSE:HIKHikma Pharmaceuticals Plc
05/02/202413:00UK RegulatoryHikma announces US launch of COMBOGESIC® IVLSE:HIKHikma Pharmaceuticals Plc
05/02/202409:46RNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
01/02/202421:00Alliance NewsAlliance NewsEARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid dealLSE:HIKHikma Pharmaceuticals Plc
01/02/202419:22RNS Regulatory NewsHikma Pharmaceuticals Plc Agreement in Principle for US Opioid SettlementLSE:HIKHikma Pharmaceuticals Plc
29/12/202308:00UK RegulatoryHikma Pharmaceuticals Plc Company Secretary ChangeLSE:HIKHikma Pharmaceuticals Plc
02/11/202309:53Alliance NewsAlliance NewsTOP NEWS: Hikma Pharmaceuticals upgrades Generics and Branded guidanceLSE:HIKHikma Pharmaceuticals Plc
03/10/202313:00PR Newswire (US)Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the USLSE:HIKHikma Pharmaceuticals Plc
30/08/202318:55Alliance NewsAlliance NewsTOP NEWS: M&S returns to FTSE 100 after four years, Persimmon exitsLSE:HIKHikma Pharmaceuticals Plc
23/08/202315:07Alliance NewsAlliance NewsIN DEPTH: M&S set for blue-chip return as Hikma-Dechra yo-yo continuesLSE:HIKHikma Pharmaceuticals Plc
22/08/202318:26Alliance NewsAlliance NewsTOP NEWS: M&S set to be FTSE 100 outfit again but Persimmon may fallLSE:HIKHikma Pharmaceuticals Plc
10/08/202314:28PR Newswire (US)Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North AfricaLSE:HIKHikma Pharmaceuticals Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HIK

La tua Cronologia

BIT
S28697
Societe Generale Effekten
LSE
0A5U
Renewcell Ab
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network